Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. (Q48354717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Karen G Welinder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

Andreasen PA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Douglas R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Sartorio R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Nielsen LS

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Oppenheimer C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Blasi F

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Danø K

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

language of work or name

English

0 references

publication date

1 December 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

213-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3025016%20AND%20SRC:MED&resulttype=core&format=json

Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

The human urokinase-plasminogen activator gene and its promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Structure and variation of human alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

How signal sequences maintain cleavage specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Amino acid sequence analysis of the glycopeptides from human complement component C3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

Cloning and expression of the cDNA for human antithrom, bin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9

The site in human antithrombin for functional proteolytic cleavage by human thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2886%2981113-9